William A. Chatfield serves as Executive at OXYGEN BIOTHERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, William A. Chatfield has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 1, 2012 involved receiving (via award) 18,961 shares valued at $33.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 1, 2012 | OXBT | $33.8K | Award | 18,961 | $1.78 | Discretionary |
William A. Chatfield currently holds 42,289 shares of OXYGEN BIOTHERAPEUTICS, INC. (OXBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William A. Chatfield has been a net neutral trader of OXBT stock. They have purchased $0 and sold $0 worth of shares.
William A. Chatfield's most recent insider trade was on May 1, 2012, when they sold 18,961 shares at $1.78 per share.
Get notified when new Form 4 filings are submitted